Results 21 to 30 of about 10,004,929 (375)

Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

The Journal of the National Comprehensive Cancer Network, 2021
This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer focuses on systemic therapy options for the treatment of metastatic colorectal cancer (mCRC), because important updates have recently been made to ...
A. Benson, A. Venook, M. Al-Hawary, M. Arain, Yi-Jen Chen, K. Ciombor, S. Cohen, H. Cooper, D. Deming, L. Farkas, I. Garrido-Laguna, J. Grem, A. Gunn, J. Hecht, S. Hoffe, J. Hubbard, S. Hunt, K. Johung, Natalie N. Kirilcuk, S. Krishnamurthi, W. Messersmith, J. Meyerhardt, E. Miller, M. Mulcahy, Steven J. Nurkin, M. Overman, A. Parikh, Hitendra R. H. Patel, K. Pedersen, L. Saltz, C. Schneider, D. Shibata, J. Skibber, C. Sofocleous, E. Stoffel, E. Stotsky-Himelfarb, C. Willett, K. Gregory, Lisa A. Gurski   +38 more
semanticscholar   +1 more source

Role of noninvasive molecular imaging in determining response [PDF]

, 2018
The intersection of immunotherapy and radiation oncology is a rapidly evolving area of preclinical and clinical investigation. The strategy of combining radiation and immunotherapy to enhance local and systemic antitumor immune responses is intriguing ...
Marciscano, Ariel E, Thorek, Daniel L.J.
core   +2 more sources

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.

Journal of Clinical Oncology, 2018
Purpose To increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events in patients treated with immune checkpoint inhibitor (ICPi) therapy.
J. Brahmer, C. Lacchetti, B. Schneider, M. Atkins, Kelly J. Brassil, J. Caterino, I. Chau, M. Ernstoff, Jennifer M. Gardner, P. Ginex, S. Hallmeyer, Jennifer Holter Chakrabarty, N. Leighl, J. Mammen, D. McDermott, A. Naing, L. Nastoupil, T. Phillips, Laura D. Porter, I. Puzanov, C. Reichner, B. Santomasso, Carole Seigel, A. Spira, M. Suarez‐Almazor, Yinghong Wang, J. Weber, J. Wolchok, John A Thompson   +28 more
semanticscholar   +1 more source

Applications of the ACGT Master Ontology on Cancer [PDF]

, 2008
In this paper we present applications of the ACGT Master Ontology (MO) which is a new terminology resource for a transnational network providing data exchange in oncology, emphasizing the integration of both clinical and molecular data.
A. Cali, A. Gómez-Pérez, A.L. Rector, B. Smith, B. Smith, C. Wittekind, J.E. Andrews, J.J. Cimino, K.H. Buetow, L. Martín, M. Tsiknakis, P. Grenon, W. Ceusters, W.A. Schulz   +13 more
core   +3 more sources

Imaging in Clinical Oncology [PDF]

Journal of Nuclear Medicine, 2015
A.D. Gouliamos, J.A. Andreou, and P.A. Kosmidis, eds. New York, NY: Springer, 2014, 609 pages, $229 The recent progress of oncologic imaging has been tremendous, and a multidisciplinary approach to each cancer patient is mandatory to ensure a longer and better life.
openaire   +2 more sources

Clinical Pharmacology of Radiotheranostics in Oncology

Clinical Pharmacology & Therapeutics, 2022
The combined use of diagnostic and therapeutic radioligands with the same molecular target, also known as theranostics, enables accurate patient selection, targeted therapy, and prediction of treatment response. Radioiodine, bone‐seeking radioligands and norepinephrine analogs have been used for many years for diagnostic imaging and radioligand therapy
Erik T. te Beek, Jacobus Burggraaf, Jaap J. M. Teunissen, Dennis Vriens   +3 more
openaire   +3 more sources

Polypharmacy in elderly cancer patients : challenges and the way clinical pharmacists can contribute in resource-limited settings [PDF]

, 2019
The aim of this study was to address the problems associated with polypharmacy in elderly cancer patients and to highlight the role of pharmacists in such cases in resource‐limited settings.
Khanal, Saval, Shrestha, Sudip, Shrestha, Sunil   +2 more
core   +2 more sources

Precision oncology: the intention-to-treat analysis fallacy. [PDF]

, 2020
It has recently been suggested that precision oncology studies should be reanalysed using the intention-to-treat (ITT) methodology developed for randomized controlled clinical trials.
Kato, Shumei, Kurzrock, Razelle, Okamura, Ryosuke, Sicklick, Jason K   +3 more
core   +1 more source

Assessing the Role of Artificial Intelligence (AI) in Clinical Oncology: Utility of Machine Learning in Radiotherapy Target Volume Delineation

Medicines, 2018
The fields of radiotherapy and clinical oncology have been rapidly changed by the advances of technology. Improvement in computer processing power and imaging quality heralded precision radiotherapy allowing radiotherapy to be delivered efficiently ...
Ian S. Boon, Tracy P. T. Au Yong, Cheng S. Boon   +2 more
doaj   +1 more source

Real-life data from an oncology infirmary in a Brazilian universitybased teaching hospital

Brazilian Journal of Oncology, 2021
Objective: Analyze data regarding patients in need of hospital care admitted in our oncology infirmary aiming for better clinical practices, clinical support and scope for financial and structural needs for institutions.
Pedro Paulo Perroni da Silva, Humberto Pinto De Matos, Luciana De Araujo Brito Buttros, Nadia Yumi Hatamoto, Ana Clara Salviato Capassi, Gabriela Filgueiras Sales, Gilson Luchezi Delgado, Luis Antonio Pires, Julia Villa Rios Borin, Mateus Sudario Alencar, Bruna Carone Dias, Marina Vieira Maia, Fernanda Paiva De Carvalho, Matheus Herculano   +13 more
doaj   +1 more source